Vir Biotechnology, Inc. Quarterly Stockholders' Equity Attributable to Parent in USD from Q4 2016 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.
Summary
Vir Biotechnology, Inc. quarterly Stockholders' Equity Attributable to Parent history and growth rate from Q4 2016 to Q1 2023.
  • Vir Biotechnology, Inc. Stockholders' Equity Attributable to Parent for the quarter ending March 31, 2023 was $1.97B, a 1.51% decline year-over-year.
Stockholders' Equity Attributable to Parent, Quarterly (USD)
Stockholders' Equity Attributable to Parent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2023 $1.97B -$30.3M -1.51% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 $2.08B +$646M +45.1% Dec 31, 2022 10-Q 2023-05-08
Q3 2022 $2.15B +$1.27B +145% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $1.95B +$1.21B +165% Jun 30, 2022 10-Q 2022-11-03
Q1 2022 $2B +$1.35B +207% Mar 31, 2022 10-Q 2022-08-09
Q4 2021 $1.43B +$715M +99.7% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $876M +$63.9M +7.87% Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $737M +$174M +30.8% Jun 30, 2021 10-Q 2022-11-03
Q1 2021 $651M +$271M +71.2% Mar 31, 2021 10-Q 2022-08-09
Q4 2020 $717M +$293M +69.1% Dec 31, 2020 10-K 2023-02-28
Q3 2020 $812M +$1.09B Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $564M +$801M Jun 30, 2020 10-Q 2021-11-04
Q1 2020 $380M +$586M Mar 31, 2020 10-Q 2021-08-05
Q4 2019 $424M +$603M Dec 31, 2019 10-K 2023-02-28
Q3 2019 -$281M -$127M -82.3% Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$237M -$115M -93.8% Jun 30, 2019 10-Q 2020-11-10
Q1 2019 -$205M Mar 31, 2019 10-Q 2020-08-11
Q4 2018 -$179M -$110M -160% Dec 31, 2018 10-K 2022-02-28
Q3 2018 -$154M Sep 30, 2018 10-Q 2019-11-19
Q2 2018 -$122M Jun 30, 2018 10-Q 2019-11-19
Q4 2017 -$68.9M -$60.9M -764% Dec 31, 2017 10-K 2021-02-25
Q4 2016 -$7.97M Dec 31, 2016 10-K 2020-03-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.